| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 771.307 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 364.888 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 616.516 | 93 |
| GSM780719 | Untreated after 4 days (C1_2) | 718.206 | 94 |
| GSM780720 | Untreated after 4 days (C2_2) | 379.873 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 674.042 | 93 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 264.877 | 86 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 434.092 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 432.332 | 90 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 263.07 | 86 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 420.446 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 430.215 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 951.814 | 95 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 437.553 | 91 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 575.151 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1061.45 | 96 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 470.427 | 91 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 627.794 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 279.38 | 87 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 289.832 | 87 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 310.223 | 88 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 322.661 | 88 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 323.321 | 88 |